Additional file 1: Table S1. of Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study

Adverse events. There were 15 cases wherein febuxostat treatment was discontinued owing to various adverse events. In most patients, the adverse events developed during the initial dosing of febuxostat at 10 mg/day. (DOCX 18 kb)